I would be very interested to know what the all cause mortality rate was in either groups.
According to data I've seen, 3 year survival for NYHA class 2 patients is roughly 70-80%.
As they measure at 30 months you would assume their survival in the control group would be towards the higher end of that range.
Now with say, a 25% mortality rate in a subgroup of 103 patients (206 with an assumed 50/50 control), that would be say 27 people died in the control group.
For a 60% reduction in mortality, that's roughly a difference of 10 people, right?
For a mortality difference of 10 patients in cohorts of 103 per arm I don't see how they got a significance of <0.037.
I haven't plugged it into an equation, but that seems like a very small difference in an N that isn't extremely large.
I know there are some stats experts in here, I'd love to be corrected.
- Forums
- ASX - By Stock
- MSB
- Phase 3 DREAM HF-1 read-out
Phase 3 DREAM HF-1 read-out, page-341
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
0.065(4.69%) |
Mkt cap ! $1.655B |
Open | High | Low | Value | Volume |
$1.39 | $1.50 | $1.38 | $7.016M | 4.856M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10425 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 44243 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10425 | 1.440 |
2 | 9000 | 1.435 |
4 | 62190 | 1.430 |
1 | 473 | 1.425 |
1 | 5000 | 1.420 |
Price($) | Vol. | No. |
---|---|---|
1.450 | 16999 | 2 |
1.455 | 17000 | 1 |
1.465 | 24896 | 3 |
1.470 | 112738 | 6 |
1.475 | 1800 | 1 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |